As the end of the transition period looms on the horizon, we are ready to face the new era of EU clinical trials with the mandatory use of CTIS.
We’ve meticulously planned the transition and adapted to the changing landscape. We’re committed to quality and compliance and fully equipped to navigate the new regulatory waters to provide you with exceptional service.
